Previous close | 0.9005 |
Open | 0.9470 |
Bid | 0.0000 x N/A |
Ask | 0.0000 x N/A |
Day's range | 0.9470 - 0.9470 |
52-week range | 0.8905 - 2.5860 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
With the business potentially at an important milestone, we thought we'd take a closer look at Immunic, Inc.'s...
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript May 8, 2024 Immunic, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Jessica Breu: Good morning, and welcome to Immunic First Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, […]
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...